Search Results for: omaveloxolone

RTA 408 (omaveloxolone)

RTA 408 (omaveloxolone) is a small molecule Nrf2 activator, being developed by Reata Pharmaceuticals in collaboration with AbbVie as a potential treatment of Friedreich’s ataxia (FA). An inherited disorder, FA is caused by ... Read more